MetLife Earnings Call Highlights Record EPS, Growth Engines

Metlife ((MET)) has held its Q4 earnings call. Read on for the main highlights of the call.

MetLife Signals Strong Momentum Despite Investment and Expense Headwinds

MetLife’s latest earnings call painted an overall upbeat picture, with management stressing strong operating momentum, record pension risk transfer (PRT) activity, expanding asset management capabilities and disciplined capital return. While some headwinds emerged — notably weaker variable investment income, a coming drag from corporate & other, and a temporary uptick in the expense ratio from the PineBridge deal — executives framed these as manageable against a backdrop of robust earnings growth, improved efficiency and steady progress on longer-term strategic goals.

Record Quarterly EPS Underscores Earnings Power

MetLife delivered a standout quarter, reporting Q4 adjusted earnings of $1.6 billion, or $2.49 per share. Excluding notable items, adjusted EPS rose to $2.58, up 24% from $2.08 a year earlier and described as the company’s highest single-quarter EPS on record. The performance highlights both top-line growth and disciplined underwriting across major businesses, reinforcing the company’s confidence in the durability of its earnings base even amid a choppy macro and rate environment.

Full-Year Targets Met or Exceeded

For the full year, MetLife effectively hit all of its key 2025 financial objectives. Adjusted earnings excluding notable items came in around $6.0 billion, or $8.89 per share, representing roughly 10% year‑over‑year growth. Adjusted return on equity landed at 16%, squarely within the targeted 15%–17% range, while the two‑year average free cash flow ratio reached 81%, beating the 65%–75% goal. The direct expense ratio improved to 11.7%, ahead of the company’s multi‑year efficiency target, underscoring progress on cost control and scale benefits.

Revenue Growth Fueled by PRT Origination

Top-line trends were robust in the quarter. Adjusted premiums, fees and other revenues rose 8% to $12.8 billion in Q4, and when including retained PRT deals, that figure surged 29% to $18.6 billion. For 2025, PRT originations surpassed $14 billion, the highest annual total in MetLife’s history. This business, which helps corporations offload pension liabilities, continues to be a major growth engine, bolstering fee income and balance sheet scale while reinforcing MetLife’s competitive positioning in the institutional retirement market.

MIM Transformed by PineBridge and AUM Growth

The acquisition of PineBridge and the formal launch of MetLife Investment Management (MIM) as its own segment mark a strategic pivot deeper into asset management. Year‑end MIM assets under management climbed to $742 billion, up from about $600 billion a year earlier — a roughly 23%–24% increase. Management emphasized that this larger, more diversified platform should support strong revenue expansion, with MIM revenues expected to grow about 30% in 2026, positioning the segment as a meaningful contributor to group earnings over time.

Asia and Latin America Drive International Momentum

International businesses continued to provide solid growth. In Asia, constant-currency sales rose 18% in 2025, with both Japan and Korea contributing, while general account AUM in the region increased 7% on a constant-currency basis. Latin America also posted strong numbers: sales grew 12% and adjusted PFOs jumped 25% in constant currency, while Q4 adjusted earnings in the region climbed 13%. These trends underscore MetLife’s ability to capture rising protection and savings demand in high‑growth markets.

Active Capital Deployment and Shareholder Returns

MetLife balanced growth investment with meaningful capital returns in 2025. Approximately $4 billion was deployed to support organic new business, including expanding high‑return franchises such as PRT and international protection. At the same time, the company returned about $2.9 billion through share repurchases and another $1.5 billion via dividends, for a total of roughly $4.4 billion, with an additional $200 million of buybacks executed in January. Holding company cash ended the year at $3.6 billion, within the targeted $3 billion–$4 billion range, signaling continued balance sheet strength and flexibility.

Record RIS Origination and Reinsurance as Strategic Tools

The Retirement & Income Solutions (RIS) segment capped a record year with $42 billion of sales in 2025, including more than $14 billion in PRT and around $11 billion of UK longevity transactions, $7 billion of which occurred in Q4 alone. MetLife also executed several large strategic reinsurance deals, including two “Chariot” transactions covering about $11 billion of liabilities and a Talcott risk transfer of roughly $10 billion. These actions help manage risk, capital and earnings volatility, while deepening the company’s role as a key player in global retirement de‑risking.

Efficiency Gains Powered by Technology and AI

Management highlighted continued progress on expense efficiency, supported by automation, AI and process redesign. The direct expense ratio fell to 11.7% in 2025, putting MetLife well ahead of its five‑year plan to achieve a 100‑basis‑point improvement toward an 11.3% target. The company framed this as evidence that its tech investments are translating into tangible cost savings and better scalability, even as it continues to invest in growth businesses and new capabilities.

Variable Investment Income Falls Short of Targets

One key soft spot in the results was variable investment income (VII). Q4 VII was $497 million, and full‑year VII totaled $1.5 billion, below the $1.7 billion target. Private equity delivered an 8.2% full‑year return, shy of the assumed 9%, while real estate and other funds also underperformed expectations. MetLife’s VII assets total about $19 billion, with roughly 45% tied to Asia, making the business somewhat sensitive to regional equity and real asset performance. While management framed the shortfall as manageable, it remains a watch‑item for investors given the contribution of VII to earnings.

Corporate & Other Set to Be a 2026 Headwind

Corporate & other posted an adjusted loss of $38 million for 2025, an improvement from the prior year. However, management cautioned that this line item will become a more meaningful drag in 2026, guiding to an after‑tax loss between $500 million and $700 million. The increased loss, tied in part to strategic initiatives and segment realignments, will weigh on consolidated earnings growth next year even as core segments continue to expand.

PineBridge to Temporarily Lift Expense Ratio

The PineBridge acquisition, while strategically important for MIM, will temporarily push up reported expenses. MetLife expects the direct expense ratio to increase by about 50 basis points in 2026 due to PineBridge, lifting the target to around 12.1% versus the prior multi‑year goal of 11.3%. Management emphasized this as a near‑term accounting and integration headwind rather than a reversal of the broader efficiency trend, reiterating its longer‑term expense ratio ambition.

Disability and Nonmedical Health See Q4 Pressure

The Group Benefits business experienced some pressure in Q4, particularly in disability. Results were affected by higher average claim severity, slightly higher incidence, and weaker recoveries in the quarter. The nonmedical health loss ratio also ticked up by about 1 percentage point for Q4, although full‑year recoveries were described as strong. While not viewed as structural deterioration, these trends introduce some near‑term volatility in an otherwise solid franchise.

Notable Items and Litigation Reserve Weigh on Results

Two notable items reduced Q4 adjusted earnings by $61 million, or roughly $0.09 per share. The main drivers were the impact of value‑added tax in Mexico and higher asbestos‑related litigation reserves recorded in corporate & other. Management emphasized that these items were non‑core and that underlying operational performance remained strong, but they nonetheless tempered headline earnings in the quarter.

Net Income Dampened by Derivatives and Trading Losses

While adjusted earnings were robust, reported net income was lower, reflecting market‑related items. Net income was about $800 million in Q4 and $3.2 billion for the full year, lagging adjusted earnings primarily due to net derivative losses tied to rising long‑term interest rates, foreign exchange movements and favorable equity markets, as well as normal trading‑related investment losses. The gap between net and adjusted earnings highlights the sensitivity of reported GAAP results to market swings and hedging outcomes.

Japan Surrenders and Macro Volatility in Focus

In Japan, surrenders ticked up slightly in Q4 following yen depreciation, introducing a modest headwind in the region. Management characterized this as a temporary response to currency moves and said it expects surrender activity to revert to long‑term assumptions in 2026. Even so, macro and FX volatility remain key risks for MetLife’s international earnings profile, particularly in markets where policyholder behavior is sensitive to currency and interest‑rate shifts.

Guidance Points to Double-Digit EPS Growth and Strong Cash Generation

Looking ahead, MetLife’s guidance reaffirms its “New Frontier” commitments and suggests continued solid growth despite acknowledged headwinds. Management is targeting double‑digit adjusted EPS growth in 2026, an adjusted ROE of 15%–17%, and a two‑year average free cash flow ratio of 65%–75%, supporting a five‑year free cash flow goal of $25 billion (with $4.9 billion already generated in 2025). For 2026, the company expects a direct expense ratio around 12.1% (reflecting PineBridge), favorable investment income of roughly $1.6 billion pretax, a corporate & other loss of $500–$700 million after tax, and an effective tax rate of 24%–26%, with share repurchases projected to be broadly in line with 2025. Segment guidance calls for Group Benefits PFO growth of 4%–7%, group life mortality ratios of 83%–88%, and nonmedical health interest‑adjusted benefit ratios of 70%–75%, supporting 7%–9% earnings growth in Group Benefits. RIS retained liabilities are expected to grow 3%–5%, with segment earnings of $1.6–$1.8 billion and general account spreads of 100–120 basis points. Asia sales and AUM are forecast to grow from mid‑single to mid‑high single digits, with earnings in the mid‑single digits; Latin America and EMEA PFOs are projected to grow in the high‑single digits, with Latin America earnings up 6%–8% including the Mexico tax impact and EMEA targeting a new quarterly run‑rate of $90–$100 million. MIM is expected to deliver about 30% revenue growth in 2026 and $240–$280 million of adjusted earnings, then compound earnings 15%–20% annually in 2027–2028, with a goal of roughly 32% operating margin by 2028.

In sum, MetLife’s earnings call showcased a company executing well on its strategy: record EPS, strong PRT and RIS growth, expanding asset management, and solid international momentum, all backed by healthy capital returns and efficient operations. While softer variable investment income, a sizable anticipated corporate & other drag, and temporary expense pressure from PineBridge are not trivial, management’s guidance and track record suggest these headwinds are outweighed by structural strengths. For investors, the story remains one of steady growth, rising cash generation and increasing scale in retirement and asset management, against a backdrop of manageable market and underwriting risks.